June 25, 2026, Lehi Valley Trading Company of Mesa, AZ, is recalling 624 units of its 15 ounce packages of High Valley Orchard Chocolate Covered Raisins because they contain undeclared peanuts. People who have allergies to peanuts run the risk of serious or life-threatening allergic reaction if they
The U.S. Department of Health and Human Services' (HHS') Office of Inspector General has issued a consumer alert, urging parents, caregivers, athletic programs and student athletes to beware of fraudulent cardiovascular testing schemes exploiting fears around sudden cardiac arrest in young athletes.
Prospective generic drug applicants and generic drug applicants who intend to use model-integrated evidence (MIE) approaches for bioequivalence (BE) establishment in their abbreviated new drug applications (ANDAs).
The American Diabetes Association Expresses Concern Over Rhode Island’s Decision to Eliminate Medicaid Coverage of Obesity Treatments mcarmody Thu, 06/25/2026 - 19:39 Advocacy News The American Diabetes Association Expresses Concern Over Rhode Island’s Decision to Eliminate Medicaid Coverage of Obesity Treatments ARLINGTON, Va. June 25, 2026 The Rhode Island General Assembly’s Fiscal Year 2027 (FY 2027) budget adopted a policy change that limits Medicaid coverage of glucagon-like peptide-1 (GLP-1)-based medications to only individuals with type 2 diabetes. Beginning October 1, 2026…
Combined assessment of LDL-C, Lp(a) and hsCRP reflected independent pathways for identifying individuals of varied ethnicities at greater long-term risk of atherosclerotic cardiovascular disease (ASCVD), according to an analysis of the HELIUS cohort published June 24 in JACC.
The mission of the Office of Pharmaceutical Quality is to assure that quality medicines are available to the American public. The annual Report on the State of Pharmaceutical Quality is intended to help characterize the quality of the U.S. drug supply chain. Learn more.
Throughout the first half of 2026, ACC’s Advocacy Team has been actively engaged in shaping policy at both the federal and state levels and working with policymakers to support cardiovascular clinicians and improve patient care nationwide. Read about key highlights from this work below.
The novel ONCO-DOAC BLEED risk score, developed by Tomoyuki Nagai, MD, et al., provided clinically relevant major bleeding risk stratification for patients with cancer-associated venous thromboembolism (VTE) receiving direct oral anticoagulants (DOAC), according to research published June 16 in JACC: CardioOncology.
Aficamten monotherapy was superior to metoprolol in promoting adaptation to multiple phases of exercise in patients with symptomatic obstructive HCM (oHCM), according to a prespecified analysis of the MAPLE-HCM trial published June 17 in JAMA Cardiology.
Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.
Clopidogrel monotherapy was associated with lower risks of major adverse cardiovascular events (MACE) and major bleeding compared with aspirin monotherapy among stable patients post PCI, according to a nationwide cohort study published June 15 in JACC: Asia.
Long-term exposure to specific chemical components of fine particulate matter with diameters ≤2.5 μm (PM2.5) was associated with an increased risk of developing cardiovascular disease, according to a large cohort study published June 24 in JACC.
The rates of mortality and reintervention at 10 years were higher in patients at intermediate risk who underwent TAVR with the second-generation SAPIEN XT valve than those who underwent surgery in the PARTNER 2A trial, according to an analysis published June 16 in a valvular heart disease focus issue of JACC.
Meet Gibran: How DKA (Ketoacidosis) Pushed Him to Take Control of His Type 1 Diabetes and Listen to His Body mseibold Thu, 06/25/2026 - 14:49 Type 1 Share Your Story By sharing your story, you help us raise awareness of diabetes so we can bend the curve on it once and for all. Will you help us awaken the world? Share Your Story
Objectives This study aims to examine the electronic prescription programme in Iran by thoroughly identifying the key strengths, weaknesses, opportunities and threats (SWOT) associated with its implementation and utilisation among healthcare stakeholders. Design A thematic analysis was adopted, with data systematically examined through the SWOT analytical framework. Setting Hospital, pharmacy, specialised clinic, insurance affiliated clinic in Iran. Participants Participants consisted of four groups involved in implementing the electronic prescription programme, including physicians…